Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion.
about
Paradoxical Roles of Antioxidant Enzymes: Basic Mechanisms and Health ImplicationsIschemia-reperfusion injury in strokeDeficiency of ataxia telangiectasia mutated kinase modulates cardiac remodeling following myocardial infarction: involvement in fibrosis and apoptosis.Loss of SOD3 (EcSOD) Expression Promotes an Aggressive Phenotype in Human Pancreatic Ductal Adenocarcinoma.Preconditioning c-Kit-positive Human Cardiac Stem Cells with a Nitric Oxide Donor Enhances Cell Survival through Activation of Survival Signaling Pathways.Genetic Deficiency of Glutathione S-Transferase P Increases Myocardial Sensitivity to Ischemia-Reperfusion Injury.Loss of Mrp1 Potentiates Doxorubicin-Induced Cytotoxicity in Neonatal Mouse Cardiomyocytes and Cardiac FibroblastsKinetic and mechanistic considerations to assess the biological fate of peroxynitrite.Reoxygenation-derived toxic reactive oxygen/nitrogen species modulate the contribution of bone marrow progenitor cells to remodeling after myocardial infarction.Extracellular superoxide dismutase is necessary to maintain renal blood flow during sepsis development.Signaling by S-nitrosylation in the heart.Cardiac myocyte-specific transgenic ecSOD targets mitochondria to protect against Ca(2+) induced permeability transitionCharacterization of oxygen radical formation mechanism at early cardiac ischemia.Low T3 State Is Correlated with Cardiac Mitochondrial Impairments after Ischemia Reperfusion Injury: Evidence from a Proteomic Approach.Exercise-induced cardioprotection: a role for eNOS uncoupling and NO metabolites.The extracellular isoform of superoxide dismutase has a significant impact on cardiovascular ischaemia and reperfusion injury during cardiopulmonary bypass.
P2860
Q28392715-1491961A-4164-4BDB-A102-BB3DF511003FQ33653045-30AA0277-EC59-4D63-B41F-5BB86B40738BQ35073104-23F0E0D0-1586-4487-947E-AB31285C60D3Q35251686-31A5571C-0DD0-4A2E-ABF1-4A83DF5270D6Q36850078-3C57D35F-4BC6-4CDC-BCF5-9A066CD4262FQ36862431-C029F198-D860-4428-9FC9-A74A1B20E310Q37023604-577FE407-1C88-4D46-996A-F0F565E7251AQ37381268-2D563894-7ADA-4267-90EC-CE9D3C6D8799Q37648491-FE1B1834-ECC4-486A-86B4-7DB90AD53E8DQ37707169-1DB26688-BF3D-4C10-8018-8C9DF1098635Q38179749-C4096932-4073-450E-ADD6-6FB7F0EFBC74Q42145276-A6D60BD8-9050-4405-B69D-F0EFD994FF67Q42149344-73C2A6D1-4F1B-403B-B5C8-C63173251BE7Q43152861-0B238A32-D219-4606-BB31-A90D478A2875Q45941940-408D41B5-189F-4373-8A65-1224B560DADAQ51247050-CE1B0F04-2EF9-43D5-8DDB-37CE1C43D0F4
P2860
Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Cardiomyocyte-restricted overe ...... ze after ischemia/reperfusion.
@ast
Cardiomyocyte-restricted overe ...... ze after ischemia/reperfusion.
@en
type
label
Cardiomyocyte-restricted overe ...... ze after ischemia/reperfusion.
@ast
Cardiomyocyte-restricted overe ...... ze after ischemia/reperfusion.
@en
prefLabel
Cardiomyocyte-restricted overe ...... ze after ischemia/reperfusion.
@ast
Cardiomyocyte-restricted overe ...... ze after ischemia/reperfusion.
@en
P2093
P2860
P1476
Cardiomyocyte-restricted overe ...... ze after ischemia/reperfusion.
@en
P2093
Aruni Bhatnagar
Daniel Conklin
Detlef Obal
Gregg Rokosh
Jay Zweier
Justin Kingery
Murugesan Velayutham
Neviana Dimova
Qianghong Li
P2860
P2888
P356
10.1007/S00395-012-0305-1
P577
2012-10-26T00:00:00Z